<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00958347</url>
  </required_header>
  <id_info>
    <org_study_id>01/04</org_study_id>
    <nct_id>NCT00958347</nct_id>
  </id_info>
  <brief_title>Omnifit Hydroxylapatite (HA) Hip Outcomes Study</brief_title>
  <official_title>Omnifit Hydroxylapatite (HA) Hip Outcomes Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Stryker Orthopaedics</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Stryker Orthopaedics</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study was to obtain up to 25 year post-operative data on the Omnifit
      Hydroxylapatite (HA) Hip System in support of the hypothesis that it is a satisfactory system
      for reducing implant loosening, permitting tissue bonding onto the hydroxylapatite surfaces
      of the implant and providing a safe, efficient, and well-functioning hip in a wide spectrum
      of clinical circumstances.
    </textblock>
  </brief_summary>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Terminated due to lagging follow-up
  </why_stopped>
  <start_date>October 1987</start_date>
  <completion_date type="Actual">May 2011</completion_date>
  <primary_completion_date type="Actual">May 2011</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Patients Will be Evaluated for Pain, Functional Level, and Clinical Complications Utilizing the Harris Hip Score.</measure>
    <time_frame>25 Years Post-Operatively</time_frame>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">226</enrollment>
  <condition>Arthroplasty, Replacement, Hip</condition>
  <arm_group>
    <arm_group_label>Omnifit HA Hip Stem</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Participants underwent total hip replacement surgery using the Omnifit HA Hip Stem.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Omnifit HA Hip Stem</intervention_name>
    <description>Total Hip Replacement with Omnifit HA Hip Stem</description>
    <arm_group_label>Omnifit HA Hip Stem</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        For use as a universal hip replacement:

          -  Acute femoral neck fracture.

          -  Non-union of femoral head and neck fractures.

          -  Aseptic necrosis of the femoral head.

          -  Osteoarthritis, rheumatoid arthritis, or post-traumatic arthritis of the hip with
             minimal acetabular involvement or distortion.

          -  Salvage of failed total hip arthroplasty.

        For use as a total hip replacement:

          -  Severely disabled joints resulting from painful osteoarthritis, rheumatoid arthritis,
             or post-traumatic arthritis.

          -  Revision of previous unsuccessful femoral head replacement, cup arthroplasty, or other
             procedure.

        Exclusion Criteria:

          -  Active infection in or near the hip joint.

          -  Pathological bone conditions which would significantly compromise the ability to carry
             physiologic stress levels and for which bone grafting would be inappropriate (i.e.
             severe osteoporosis, Paget's Disease, renal osteodystrophy, etc.).

          -  Neuro-muscular disorders in which the potentially adverse effects on prosthesis
             function are not outweighed by the benefits to be gained by the patient from usage of
             the implant.

          -  Mental disorders which would compromise essential patient post-operative care.

          -  Skeletal immaturity.

          -  Extreme obesity.

          -  Significant probability that patient could not return for required follow-up
             evaluations.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>William Capello, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Indiana University School of Medicine</affiliation>
  </overall_official>
  <overall_official>
    <last_name>William Jaffe, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital for Joint Disease/ Orthopaedic Institute</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Rudolph Geesink, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Trialbureau Orthopedics</affiliation>
  </overall_official>
  <overall_official>
    <last_name>James D'Antonio, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Sewickley Valley Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Indiana University Medical Center</name>
      <address>
        <city>Indianapolis</city>
        <state>Indiana</state>
        <zip>46202</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital for Joint Disease/ Orthopaedic Institute</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10128</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sewickley Valley Hospital</name>
      <address>
        <city>Moon Township</city>
        <state>Pennsylvania</state>
        <zip>15108-4305</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Trialbureau Orthopedics</name>
      <address>
        <city>Maastricht</city>
        <zip>6202</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Netherlands</country>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 11, 2009</study_first_submitted>
  <study_first_submitted_qc>August 12, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 13, 2009</study_first_posted>
  <results_first_submitted>July 30, 2014</results_first_submitted>
  <results_first_submitted_qc>July 30, 2014</results_first_submitted_qc>
  <results_first_posted type="Estimate">August 19, 2014</results_first_posted>
  <last_update_submitted>July 30, 2014</last_update_submitted>
  <last_update_submitted_qc>July 30, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 19, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>

  <clinical_results>

    <participant_flow>
      <pre_assignment_details>226 participants = 262 hips</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Omnifit HA Hip Stem</title>
          <description>Omnifit HA Hip Stem: Total Hip Replacement with Omnifit HA Hip Stem.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="226"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0">11 revisions total, one was a bilateral participant with the other hip counted as not completed.</participants>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="226"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Death</title>
              <participants_list>
                <participants group_id="P1" count="43"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="23"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="15"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>revision/removal</title>
              <participants_list>
                <participants group_id="P1" count="10"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>study termination</title>
              <participants_list>
                <participants group_id="P1" count="135"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Omnifit HA Hip Stem</title>
          <description>Omnifit HA Hip Stem: Total Hip Replacement with Omnifit HA Hip Stem</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="226"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <description>For bilateral total hip replacement participants, the age at the time of the initial hip replacement surgery is used.</description>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="51.55" spread="10.83"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="113"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="113"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Patients Will be Evaluated for Pain, Functional Level, and Clinical Complications Utilizing the Harris Hip Score.</title>
        <time_frame>25 Years Post-Operatively</time_frame>
        <population>The study was closed and no subjects reached the 25 year postoperative endpoint.</population>
        <group_list>
          <group group_id="O1">
            <title>Omnifit HA Hip Stem</title>
            <description>Omnifit HA Hip Stem: Total Hip Replacement with Omnifit HA Hip Stem</description>
          </group>
        </group_list>
        <measure>
          <title>Patients Will be Evaluated for Pain, Functional Level, and Clinical Complications Utilizing the Harris Hip Score.</title>
          <population>The study was closed and no subjects reached the 25 year postoperative endpoint.</population>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>22 years</time_frame>
      <desc>Elective procedures are not included. These may include: non-study total knee/hip replacements/revisions, rotator cuff repairs, carpal tunnel releases, cataract &amp; intra-ocular procedures, bunion procedures, total shoulder repairs, laminectomies, microdiscectomies, breast reductions, cervical spine fusions, &amp; mid-foot/flat-foot surgeries.</desc>
      <group_list>
        <group group_id="E1">
          <title>Omnifit HA Hip Stem</title>
          <description>Omnifit HA Hip Stem: Total Hip Replacement with Omnifit HA Hip Stem</description>
        </group>
      </group_list>
      <serious_events>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="104" subjects_at_risk="226"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Non-operative Site Cardiac Disorders</sub_title>
                <counts group_id="E1" events="13" subjects_affected="13" subjects_at_risk="226"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Non-operative Site Gastrointestinal Disorders</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="226"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Non-operative Site Infections and Infestations</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="226"/>
              </event>
              <event>
                <sub_title>Operative Site Infection and Infestation</sub_title>
                <counts group_id="E1" events="3" subjects_affected="2" subjects_at_risk="226"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Non-operative Site Musculoskeletal and Connective Tissue Disorders</sub_title>
                <counts group_id="E1" events="9" subjects_affected="9" subjects_at_risk="226"/>
              </event>
              <event>
                <sub_title>Operative Site Musculoskeletal and Connective Tissue Disorders</sub_title>
                <counts group_id="E1" events="122" subjects_affected="81" subjects_at_risk="226"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Neoplasms benign, malignant and unspecified (incl cysts and polyps)</title>
            <event_list>
              <event>
                <sub_title>Non-Operative Site Neoplasms Benign,Malignant,and Unspecified</sub_title>
                <counts group_id="E1" events="7" subjects_affected="7" subjects_at_risk="226"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>Non-operative Site Renal and Urinary Disorders</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="226"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Operative Site Skin and Subcutaneous Tissue Disorders</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="226"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>Non-operative Site Vascular Disorders</sub_title>
                <counts group_id="E1" events="9" subjects_affected="9" subjects_at_risk="226"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="70" subjects_at_risk="226"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Non-operative Site Musculoskeletal and Connective Tissue Disorder</sub_title>
                <counts group_id="E1" events="26" subjects_affected="19" subjects_at_risk="226"/>
              </event>
              <event>
                <sub_title>Operative Site Musculoskeletal and Connective Tissue Disorder</sub_title>
                <counts group_id="E1" events="75" subjects_affected="59" subjects_at_risk="226"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>For 7 years from and after termination date of the agreement, prior to submission for publication of abstracts, manuscripts, presentations or other communications describing the results of any aspect of the Study (&quot;Manuscript&quot;), You and the Institution shall send Stryker Orthopaedics a copy of the Manuscript to be submitted, and allow Stryker Orthopaedics sixty (60) days from the date of receipt to review the Manuscript.</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Director of Clinical Research</name_or_title>
      <organization>Stryker Orthopaedics</organization>
      <phone>201-831-5401</phone>
      <email>ellen.axelson@stryker.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

